Literature DB >> 29913129

Philadelphia chromosome-positive lymphoblastic lymphoma-Is it rare or underdiagnosed?

Ahmad Alshomar1, Riad El Fakih2.   

Abstract

Lymphoblastic lymphomas (LBLs) are neoplasms of precursor B and T cells; they are considered in the same spectrum as precursor B and T cell acute lymphoblastic leukemia (ALL). The World Health Organization classification classifies both LBL and ALL as one disease entity. While chromosome abnormalities are well defined with all of their therapeutic and prognostic implications in ALL, these are not well studied in LBL. Here, we describe a case of Philadelphia chromosome-positive LBL and review the available literature regarding this entity.
Copyright © 2018 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lymphoblastic lymphomas; Philadelphia chromosome-positive

Year:  2018        PMID: 29913129     DOI: 10.1016/j.hemonc.2018.05.007

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  2 in total

1.  Primary Testicular and Cutaneous Philadelphia Chromosome Positive B-Cell Lymphoblastic Lymphoma: A Rare Case and Review.

Authors:  Qiuxia Yu; Gaoxiang Wang; Jue Wang; Wei Zhang; Li Meng; Yang Cao
Journal:  Cancer Manag Res       Date:  2022-04-21       Impact factor: 3.602

2.  Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.

Authors:  Xiaoning Li; Weijie Cao; Suping Zhang; Li Li; Yingmei Li; Zhongxing Jiang; Dingming Wan; Jifeng Yu
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.